ArticleFrontiers in oncology2024

Large-scale, prospective observational study of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors in a real-world clinical setting.

Yoshito Komatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.